Barazzoni Rocco, Zanetti Michela, Ferreira Clara, Vinci Pierandrea, Pirulli Alessia, Mucci Mariapia, Dore Franca, Fonda Maurizio, Ciocchi Beniamino, Cattin Luigi, Guarnieri Gianfranco
Clinica Medica, Department of Clinical, Morphological and Technological Sciences, University of Trieste, Ospedale Cattinara, Strada di Fiume 447, 34127 Trieste, Italy.
J Clin Endocrinol Metab. 2007 Oct;92(10):3935-40. doi: 10.1210/jc.2006-2527. Epub 2007 Jul 24.
Metabolic syndrome shows clustered metabolic abnormalities with major roles for insulin resistance and obesity. Ghrelin is a gastric hormone whose total plasma concentration (T-Ghr) is associated positively with insulin sensitivity and is reduced in obesity. Ghrelin circulates in acylated (A-Ghr) and desacylated (D-Ghr) forms, but their potential differential associations with insulin resistance and whether they are differentially altered in obesity remain undefined.
Our objective was to determine potential differential associations of ghrelin forms with insulin resistance [homeostasis model assessment of insulin resistance (HOMA-IR)] and the impact of obesity on their plasma concentrations in metabolic syndrome.
This is a cross-sectional study.
The study was performed in a metabolic outpatient unit.
Patients with metabolic syndrome (National Cholesterol Education Program-Adult Treatment Panel III; n = 45, 23 males/22 females) were included in the study.
The main study outcomes were metabolic syndrome criteria, HOMA-IR, and ghrelin forms.
Plasma insulin and HOMA-IR were associated negatively with T-Ghr and D-Ghr but positively with A-Ghr and acylated to desacylated ghrelin (A/D-Ghr) ratio (n = 45; P < 0.05). Compared with nonobese [body mass index (BMI) < 27.5 kg/m(2); n = 12, six males/six females], obese metabolic syndrome patients (BMI > 27.5 kg/m(2); n = 33) had lower T-Ghr and D-Ghr but comparable A-Ghr and higher A/D-Ghr ratio (P < 0.05). BMI and waist circumference (WC) were positively related with HOMA-IR (n = 45; P < 0.05). However, opposite associations between A/D-Ghr ratio and HOMA-IR remained significant after adjustment for sex and BMI (or WC). Additional obese individuals without metabolic syndrome (n = 10: age-, sex-, BMI-, and WC-matched to obese metabolic syndrome patients) had lower T-Ghr but higher A-Ghr (P < 0.05) compared with age-, sex-matched healthy nonobese counterparts (n = 15). T-Ghr and A-Ghr were comparable in obese with or without metabolic syndrome.
Obesity could alter circulating ghrelin profile, and relative A-Ghr excess could contribute to obesity-associated insulin resistance in metabolic syndrome.
代谢综合征表现为聚集性代谢异常,胰岛素抵抗和肥胖起主要作用。胃饥饿素是一种胃激素,其血浆总浓度(T-Ghr)与胰岛素敏感性呈正相关,在肥胖症中降低。胃饥饿素以酰化形式(A-Ghr)和去酰化形式(D-Ghr)循环,但它们与胰岛素抵抗的潜在差异关联以及在肥胖症中是否存在差异改变仍不明确。
我们的目的是确定胃饥饿素不同形式与胰岛素抵抗[胰岛素抵抗稳态模型评估(HOMA-IR)]的潜在差异关联,以及肥胖对代谢综合征患者血浆浓度的影响。
这是一项横断面研究。
研究在代谢门诊进行。
纳入了代谢综合征患者(美国国家胆固醇教育计划成人治疗小组第三次报告标准;n = 45,23名男性/22名女性)。
主要研究结局为代谢综合征标准、HOMA-IR和胃饥饿素形式。
血浆胰岛素和HOMA-IR与T-Ghr和D-Ghr呈负相关,但与A-Ghr和酰化与去酰化胃饥饿素比值(A/D-Ghr)呈正相关(n = 45;P < 0.05)。与非肥胖者[体重指数(BMI)< 27.5 kg/m²;n = 12,6名男性/6名女性]相比,肥胖的代谢综合征患者(BMI > 27.5 kg/m²;n = 33)的T-Ghr和D-Ghr较低,但A-Ghr相当,A/D-Ghr比值较高(P < 0.05)。BMI和腰围(WC)与HOMA-IR呈正相关(n = 45;P < 0.05)。然而,在调整性别和BMI(或WC)后A/D-Ghr比值与HOMA-IR之间的相反关联仍然显著。另外,与年龄、性别匹配的健康非肥胖者(n = 15)相比,无代谢综合征的额外肥胖个体(n = 10:年龄、性别、BMI和WC与肥胖的代谢综合征患者匹配)的T-Ghr较低,但A-Ghr较高(P < 0.05)。有或无代谢综合征的肥胖者的T-Ghr和A-Ghr相当。
肥胖可改变循环中的胃饥饿素谱,相对的A-Ghr过量可能导致代谢综合征中与肥胖相关的胰岛素抵抗。